Aurobindo Pharma to invest Rs 300 crore on mammalian cell culture manufacturing facility
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
Post-acquisition, Cipla EU's stake in the subsidiary will increase to 93.10%.
Chlorthalidone Tablets USP, 25 mg and 50 mg, have an estimated market size of US $37 million for twelve months ending June, 2022 according to IQVIA
New mass spectrometry instrument and consumables launch during IMSC 2022
The RRA was conducted from 22nd August, 2022 to 26th August, 2022.
The unit has filed 2 Derma products and 1 MDI product.
he approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Hygroton Tablets, 25 mg and 50 mg, of Sanofi Aventis US. LLC (Sanofi).
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
Subscribe To Our Newsletter & Stay Updated